Toxicological study and efficacy of blank and paclitaxel-loaded lipid nanocapsules after i.v. administration in mice.

Pharm Res 2010 Mar;27(3):421-30

Pulmonology Department, Academic Hospital, Angers, 49933, France.

Purpose: Lipid nanocapsules (LNCs) are solvent-free drug nanocarriers permitting entrapment of paclitaxel and increasing its antitumoural effect in animal models after i.v. injection. The tolerance and efficacy of LNCs after repeated dose i.v. administration were assessed in mice. The maximum tolerated dose (MTD) and 50 percent lethal dose (LD50) were studied.

Methods: Paclitaxel-loaded LNC formulation was given i.v. at the dose of 12 mg/kg per day for 5 consecutive days in comparison with blank LNCs and saline. Histological examination, complete blood counts and biochemical quantification were performed after a recovery of 7 days. Growth of NCI-H460 subcutaneous xenografts in nude mice receiving one of the aforementioned schedules was assessed. MTD and LD50 were determined by Irwin test.

Results: No mortality was observed in repeated injections studies. Histological studies revealed no lesions and no accumulation of lipids. Blood studies were normal. The tumoural growth was significantly reduced in the group treated by paclitaxel-loaded LNCs. The MTDs/LD50s of Taxol, paclitaxel-loaded LNCs and blank LNCs were 12/19.5, 96/216 and above 288/288 mg/kg, respectively.

Conclusions: This study demonstrates that a five-day i.v. injection schedule of paclitaxel-loaded LNC dispersions induces no histological or biochemical abnormalities in mice and improves paclitaxel efficacy and therapeutic index in comparison with Taxol.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11095-009-0024-yDOI Listing
March 2010
15 Reads

Publication Analysis

Top Keywords

paclitaxel-loaded lncs
8
blank lncs
8
paclitaxel-loaded lnc
8
lipid nanocapsules
8
lncs
6
paclitaxel-loaded
5
respectivelyconclusions study
4
performed recovery
4
recovery days
4
quantification performed
4
biochemical quantification
4
counts biochemical
4
study demonstrates
4
days growth
4
growth nci-h460
4
xenografts nude
4
nude mice
4
288/288 mg/kg
4
subcutaneous xenografts
4
mg/kg respectivelyconclusions
4

References

(Supplied by CrossRef)

EK Rowinsky et al.
N Engl J Med 1995

N Klauber et al.
Cancer Res 1997

ME Stearns et al.
Cancer Res 1992

D Dyeand et al.
Br Med J 1980

RB Weiss et al.
J Clin Oncol 1990

L Zuylen van et al.
Cancer Chemother Pharmacol 2001

AG Bagnarello et al.
N Engl J Med 1977

M Kongshaug et al.
Int J Biochem 1991

K Woodburnand et al.
J Photochem Photobiol B 1994

T Shimomura et al.
Lancet 1998

CD Scripture et al.
Curr Neuropharmacol 2006

Similar Publications